Thinking “Green” When Treating “Pink Puffers” and “Blue Bloaters”—Reducing Carbon Footprint When Prescribing Inhalers

Journal of the American Board of Family Medicine: JABFM

article

Harland T. Holman¹  Michael J. Bouthillier¹  Frank Müller¹ 

[1]Department of Family Medicine, Michigan State University

[2]College of Pharmacy, Ferris State University

关键词: Asthma;    Carbon Dioxide;    Carbon Footprint;    Climate Change;    COPD;    Drug Prescriptions;    Dry Powder Inhalers;    Environmental Medicine;    Family Medicine;    Global Warming;    Greenhouse Gases;    Metered Dose Inhalers;    Norflurane;   

DOI  :  10.3122/jabfm.2022.220292R2

学科分类：过敏症与临床免疫学

来源: The American Board of Family Medicine

【 摘 要 】

The impact of man-made climate change is already affecting millions of people worldwide. The health care sector in the US is a relevant contributor, accounting for about 8 to 10% of national greenhouse gas emissions. This special communication describes the harmful impact of propellant gases in metered dose inhalers (MDI) on the climate and summarizes and discusses current knowledge and recommendations from European countries. Dry powder inhalers (DPI) are a good alternative to MDIs and are available for all inhaler drug classes recommended in current asthma and COPD guidelines. Changing an MDI to PDI can significantly reduce carbon footprints. The majority of the US population is willing to do more to protect the climate. Primary care providers can engage in this by addressing the impacts of drug therapy on climate change in medical decision making.

【 授权许可】

CC BY